NCCN Guidelines Revisions and ASCO 2024 Research NCCN Guidelines Revisions and ASCO 2024 Research Outlook Outlook

An oncologist specializing in breast cancer treatment reviews the latest guideline recommendations for systemic therapies in HR+/HER2- breast cancer, comparing the available CDK4/6 inhibitors and discussing considerations for optimal treatment sequencing.

EP: 1.NCCN Guidelines Recommend Capivasertib, Fulvestrant for Certain Patients With Breast Cancer

EP: 2.Breast Cancer Treatment: NCCN Guideline Updates and Optimism at ASCO 2024

EP: 3.Sequencing CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Treatment

EP: 4.Tailoring CDK4/6 Inhibitor Treatment to Patient Needs

EP: 5.NCCN Guidelines for Early-Stage Breast Cancer: Abemaciclib and Ribociclib

EP: 6.Exploring Results from CAPItello-291 Trial

EP: 7.Exploring Biomarker Testing and Personalized Treatments in Breast Cancer

Now Viewing

EP: 8.NCCN Guidelines Revisions and ASCO 2024 Research NCCN Guidelines Revisions and ASCO 2024 Research Outlook Outlook

EP: 9.Emerging Breast Cancer Therapies and Closing Thoughts

1. How do you think the revised NCCN Guidelines for breast cancer will impact patient outcomes?
2. What data, results, or insights are you looking forward to coming out of ASCO 2024?

Related Videos

Related Content

Advertisement

September 6th 2024

Two Leukemia Stem Cell Subtypes Identified

Karen Jacobson-Sive

Researchers have discovered 2 leukemia stem cell subtypes with distinct epigenetic and transcriptional signatures.

July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

September 6th 2024

Combining Infrared Spectroscopy, AI May Influence More Reliable Diagnosis of MG

AJMC Contributor

If integrated into clinical practice, the approach could fill a need for more optimal diagnostic approaches for myasthenia gravis (MG), explained the researchers.

May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi

In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.

September 6th 2024

ESC 2024: Advancing Care With New Cardiovascular Research

Maggie L. Shaw

At the 2024 European Society of Cardiology Congress (ESC), key research in cardiology care included studies conducted on cardiovascular disease risk among women, cardiac distress and smoking, and lipoprotein(a).

September 5th 2024

Patients With Vitiligo Experience Poorer Quality of Life but Greater Health Care Access, Utilization

Brooke McCormick

Compared with those without vitiligo, patients with vitiligo have higher health care access and utilization but report a lower quality of life.

Related Content

Advertisement

September 6th 2024

Two Leukemia Stem Cell Subtypes Identified

Karen Jacobson-Sive

Researchers have discovered 2 leukemia stem cell subtypes with distinct epigenetic and transcriptional signatures.

July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

September 6th 2024

Combining Infrared Spectroscopy, AI May Influence More Reliable Diagnosis of MG

AJMC Contributor

If integrated into clinical practice, the approach could fill a need for more optimal diagnostic approaches for myasthenia gravis (MG), explained the researchers.

May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi

In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.

September 6th 2024

ESC 2024: Advancing Care With New Cardiovascular Research

Maggie L. Shaw

At the 2024 European Society of Cardiology Congress (ESC), key research in cardiology care included studies conducted on cardiovascular disease risk among women, cardiac distress and smoking, and lipoprotein(a).

September 5th 2024

Patients With Vitiligo Experience Poorer Quality of Life but Greater Health Care Access, Utilization

Brooke McCormick

Compared with those without vitiligo, patients with vitiligo have higher health care access and utilization but report a lower quality of life.